Sage Bionetworks is located in Seattle, WA. The organization was established in 2010. According to its NTEE Classification (U50) the organization is classified as: Biological & Life Sciences, under the broad grouping of Science & Technology and related organizations. As of 12/2021, Sage Bionetworks employed 138 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Sage Bionetworks is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Sage Bionetworks generated $26.4m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 19.3% each year . All expenses for the organization totaled $25.2m during the year ending 12/2021. While expenses have increased by 17.0% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Sage Bionetworks has awarded 73 individual grants totaling $8,698,050. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
SAGE BIONETWORKS IS A STRATEGIC RESEARCH ORGANIZATION WITH A MISSION TO COORDINATE AND LINK ACADEMIC AND COMMERCIAL BIOMEDICAL RESEARCHERS, PATIENTS AND CITIZENS THROUGH A COMMONS THAT REPRESENTS A NEW PARADIGM FOR GENOMICS INTELLECTUAL PROPERTY, RESEARCHER COOPERATION AND CONTRIBUTOR EVOLVED RESOURCES. THIS MISSION HAS SEVERAL INTERDEPENDENT THEMES, INCLUDING: CONDUCTING RESEARCH ON NETWORK MODELS OF DISEASE; BUILDING THE COMPUTATIONAL PLATFORM FOR THE COMMONS; AND ACTIVATING PUBLIC ENGAGEMENT.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH COMMUNITIES AND CHALLENGES: SAGE BIONETWORKS CONDUCTS RESEARCH INDEPENDENTLY AS WELL AS WITH COLLABORATORS WORLDWIDE ACROSS A VARIETY OF DISEASE AREAS. WE WORK TO REDEFINE HOW COMPLEX BIOLOGICAL DATA IS GATHERED, SHARED AND USED THROUGH OPEN SYSTEMS, INCENTIVES, AND NORMS. OUR WORK INCLUDES THE BUILDING OF PLATFORMS AND SERVICES AND UNDERTAKING RESEARCH DEVELOPING PREDICTORS RELATING TO HEALTH. RESEARCH: AS BIOLOGICAL RESEARCH HAS BECOME MORE DATA INTENSIVE, THE BREADTH OF DATA AND EXPERTISE REQUIRED TO ADDRESS RESEARCH PROBLEMS HAS EXPANDED. IT REQUIRES THE INTEGRATED EFFORTS OF A DISTRIBUTED SET OF RESEARCHERS (SUCH AS BENCH/DATA SCIENTISTS, DATA ENGINEERS, PROJECT MANAGERS, ADMINISTRATORS, GOVERNANCE EXPERTS, AND CLINICAL RESEARCHERS) WITH SHARED INTERESTS AND COMPLEMENTARY RESOURCES. EFFECTIVE COLLABORATION DEPENDS ON A COLLECTIVE ABILITY TO WORK TOGETHER IN TRUSTED WAYS THAT LEAD TO TRANSLATABLE BIOMEDICAL INSIGHTS. WE CALL THIS SCIENTIFIC COORDINATION. SAGE'S SCIENTIFIC COORDINATION STACK INCLUDES: 1) HYPOTHESIS AND DATA GENERATION, 2) DATA CURATION, 3) ANALYSIS, 4) INTERPRETATION, AND 5) DISSEMINATION. WE FOCUS ON BUILDING A FEDERATED NETWORK OF INDIVIDUALS WHO BRING DIVERSE EXPERTISE AND APPROACHES TO DEVELOP ROBUST SOLUTIONS. RESEARCH PROJECTS INCLUDE AGORA, AGORA SUPPLEMENT TO THE UNIVERSITY OF ARIZONA, AGORA SUPPLEMENT TO MCGILL UNIVERSITY, AMP AD AND SUPPLEMENTS FOR INGESTION, LONGEVITY, MULTI SCALE, BOSTON UNIVERSITY, DIVERSITY COHORTS MAY, TREAT AD, MODEL AD, M2OVE CONSORTIUM, RISK VARIANTS, DEPRESSION EMORY, BUADC, HELMSLEY VEIOBD, BOSTON CHILDREN'S HOSPITAL VEIOBD, CSBC, CHOP INCLUDE, IMCORE, CTF SYNODOS, JHU NTAP, GFF NF, GRAY FOUNDATION, GATES COVID COHORT, HTAN, HTAN SUPPLEMENT, IATLAS 3, AACR GENIE, CD2H, CD2H COVID SUPPLEMENT, ROCHESTER UDALL, MAYO SUBTYPING, FHCRC ACCELERATOR IN ADDITION TO OTHER PROJECTS. CHALLENGES: WITH ALGORITHMS PLAYING AN INCREASING ROLE IN BIOMEDICAL ANALYSIS AND PATIENT CARE, THERE'S A NEED FOR A MORE RIGOROUS FRAMEWORK FOR EVALUATING AND IMPROVING THE CAPABILITIES OF THESE ALGORITHMS. SAGE BIONETWORKS HAS PIONEERED THE DEVELOPMENT OF CONCEPTS AND INFRASTRUCTURE TO OBJECTIVELY EVALUATE ALGORITHMS ACROSS A BROAD SPECTRUM OF BIOMEDICAL DOMAINS, INCLUDING BIOINFORMATICS, BIOMEDICAL INFORMATICS, AND CLINICAL TRIALS. AS A TRUSTED PARTNER IN HOSTING CHALLENGES AND BENCHMARKING INITIATIVES, SAGE SERVES AS A BROKER BETWEEN DATA GENERATORS AND DATA MODELERS. WE COMBINE TECHNOLOGY WITH BIOMEDICAL AND DATA SCIENCE EXPERTISE TO FACILITATE THE OBJECTIVE ASSESSMENT OF ALGORITHMS ON CRITICAL DATA SETS, INCLUDING PROPRIETARY DATA AND ALGORITHMS THAT CANNOT BE BROADLY SHARED. SAGE WORKS WITH THE DREAM COMMUNITY TO HOST OPEN CHALLENGES. DREAM IS RECOGNIZED AS A LEADER IN BIOMEDICAL COMPETITIONS, SUCCESSFULLY MOTIVATING RESEARCH TEAMS TO ADDRESS FUNDAMENTAL QUESTIONS ABOUT SYSTEMS BIOLOGY AND TRANSLATIONAL MEDICINE AND TO ADVANCE COMPUTATIONAL METHODS. DREAM CHALLENGES INVITE PARTICIPANTS TO PROPOSE SOLUTIONS - FOSTERING COLLABORATION AND BUILDING COMMUNITIES IN THE PROCESS. SAGE BIONETWORKS PROVIDES INSTITUTIONAL SUPPORT, ALONG WITH THE INFRASTRUCTURE TO HOST CHALLENGES VIA OUR SYNAPSE PLATFORM. ACTIVE CHALLENGES HOSTED ON THE SYNAPSE PLATFORM IN 2021 INCLUDED: ITCR NIH, ANIT-PDI RESPONSE PREDICTION DREAM, AND ELECTRONIC MEDICAL RECORD NLP DREAM.
DIGITAL HEALTH: SMARTPHONES AND OTHER WEARABLE SENSORS HAVE PUT TOUCHSCREENS AND HIGH-FIDELITY SENSORS INTO THE POCKETS OF BILLIONS OF PEOPLE. THESE TECHNOLOGIES PROVIDE AN OPPORTUNITY TO PAINT A RICH UNDERSTANDING OF HEALTH AND DISEASE IN THE EVERYDAY WORLD OUTSIDE OF THE CLINIC. THEY ALSO PROVIDE COMMUNICATION TOOLS THAT ALLOW PARTICIPANTS A MORE ACTIVE VOICE IN RESEARCH PROGRAMS. WITH OUR DIGITAL HEALTH PROGRAM, WE WORK TO ADVANCE HEALTH RESEARCH THROUGH PRACTICES THAT SUPPORT THE DESIGN, DEVELOPMENT AND IMPLEMENTATION OF STUDIES THAT USE TECHNOLOGY TO MONITOR HEALTH OUTSIDE OF THE CLINICAL SETTING, AND THE ANALYSIS AND SHARING OF THE RESULTING STUDY DATA. WE HELP TO DERIVE AND TEST DIGITAL BIOMARKERS. WE EVALUATE ANALYTICAL METHODOLOGIES TO BENCHMARK BEST PRACTICES IN STUDY DESIGN AND DATA ANALYSIS. SAGE'S DIGITAL HEALTH PROGRAM IS BUILT AROUND BRIDGE, A TECHNOLOGY PLATFORM FOR CONDUCTING BIOMEDICAL RESEARCH STUDIES PRIMARILY USING THE RESEARCHKIT (IOS) AND RESEARCHSTACK (ANDROID) FRAMEWORKS. BRIDGE IS COMPOSED OF HIPAA-COMPLIANT WEB SERVICES AND MULTI-LANGUAGE SDKS THAT FACILITATE: REGISTRATION AND INFORMED CONSENT TO PARTICIPATE IN RESEARCH; WEB-BASED TOOLS TO DESIGN AND SCHEDULE STUDY SURVEYS AND SENSOR-BASED TASKS; ACQUISITION AND SECURE TRANSFER OF MULTIPLE DATA TYPES (SURVEYS, SENSORS, AUDIO, VIDEO, OR CUSTOM DATA TYPES); A STUDY MANAGEMENT PORTAL WITH DAILY DASHBOARD UPDATES; AND DE-IDENTIFICATION AND STORAGE OF STUDY DATA IN OUR COLLABORATIVE DATA SCIENCE ENVIRONMENT, SYNAPSE. DIGITAL HEALTH STUDIES ACTIVE IN 2021 INCLUDED: SCRIPPS AOU, NWU TOOLBOX, BIOMARIN PKU, DIAN, PSCORCAST, MGH AT HOME, COLUMBIA CZI COVID REGISTRY, WELLCOME TRUST DATABANK, ADDF DIGITAL ACCELERATORS, M2C2, CLEVELAND CLINIC INFORMED CONSENT, RECOVER MOBILE HEALTH PLATFORM/MOVILE HEALTH REPOSITORIES WORKING GROUP, 1KD PROGRAM FUNDED BY WELLCOME LEAP INC, AND VA MERIT.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Lara Mangravite President | Officer | 50 | $278,073 |
Mike Kellen Chief Technology Officer | Officer | 50 | $229,674 |
Larsson Omberg Vice President, Systems Biology | Officer | 50 | $191,141 |
Bruce Hoff Director, Synapse Team | 50 | $185,597 | |
Diane Gary Secretary | Officer | 50 | $179,764 |
Erin Mounts Director, Bridge Platforms | 50 | $178,329 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Stockard Simon It Design | 12/30/19 | $152,910 |
Chou Communications Communications And Outreach Services | 12/30/19 | $157,111 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $15,978,511 |
All other contributions, gifts, grants, and similar amounts not included above | $1,961,618 |
Noncash contributions included in lines 1a–1f | $267,248 |
Total Revenue from Contributions, Gifts, Grants & Similar | $17,940,129 |
Total Program Service Revenue | $8,456,518 |
Investment income | $80 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $26,396,727 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $2,823,993 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $1,129,020 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $1,414,508 |
Compensation of current officers, directors, key employees. | $251,087 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $10,861,684 |
Pension plan accruals and contributions | $641,894 |
Other employee benefits | $1,358,910 |
Payroll taxes | $780,495 |
Fees for services: Management | $18,490 |
Fees for services: Legal | $397,740 |
Fees for services: Accounting | $135,390 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $3,693,972 |
Advertising and promotion | $37,672 |
Office expenses | $137,736 |
Information technology | $356,241 |
Royalties | $0 |
Occupancy | $727,781 |
Travel | $26,927 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $5,022 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $19,114 |
Insurance | $55,277 |
All other expenses | $586,778 |
Total functional expenses | $25,208,644 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $3,014,650 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $4,020,715 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $215,782 |
Net Land, buildings, and equipment | $68,693 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $7,319,840 |
Accounts payable and accrued expenses | $1,762,734 |
Grants payable | $0 |
Deferred revenue | $1,384,007 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $10,150 |
Other liabilities | $187,909 |
Total liabilities | $3,344,800 |
Net assets without donor restrictions | $3,975,040 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $7,319,840 |
Over the last fiscal year, Sage Bionetworks has awarded $2,823,993 in support to 15 organizations.
Grant Recipient | Amount |
---|---|
Roseville, CA PURPOSE: Perform Psorcast validation studies, provide input and guidance throughout the development and execution of the study. | $608,750 |
UNIVERSITY OF WASHINGTON PURPOSE: Wellcome is engaging the Supplier as a learning partner to prototype and test best ways to build a Global Mental Health Databank (GMH Databank) that holds rich longitudinal data at scale from different global locations on approaches, treatments and interventions potentially relevant to anxiety or depression in 14- 24 year olds in order to help answer the question: "what works for whom and why in relation to prevention, treatment, stopping relapse or managing ongoing difficulties for anxiety or depression including at least some 14-24 year olds" (the "Global Mental Health Databank" or "GMH Databank"). | $483,847 |
Renton, WA PURPOSE: A data and analytic platform for immuno-oncology community. | $254,417 |
Rochester, MN PURPOSE: i) Enhance natural language processing (NLP) capabilities across CTSA institutions through community engagement and ii) Accelerate the use of clinical narratives for rapid COVID-19 clinical research through team science collaboration. | $230,970 |
Oakland, CA PURPOSE: The UCLA team will lead evaluation and testing of new Synapse features, and their incorporation into multiple challenges, including a lead study of prostate cancer Active Surveillance. In all years of the grant, Dr. Boutros and the two Data Scientists will provide strategic advice, feature-testing and -development, usage-scenarios and intensive testing. Dr. Boutros will also work closely with the Clinical Advisory Board to ensure the clinical and translational value of the research. Dr. Boutros will further be responsible for regular supervision of the UCLA team, overseeing data collection and analysis, as well as mentorship and management for those personnel. Dr. Boutros will also be responsible throughout the entire grant for coordination with MPI Guinney. | $215,038 |
OREGON HEALTH & SCIENCE UNIVERSITY PURPOSE: Existing computational methods for single-cell RNA-seq signal correction and single-cell ATAC-seq peak quantification will be evaluated to select baseline methods respectively for each task, for comparison in the competition. An evaluation criteria will be developed for universal assessment of the participating computational approaches using public and in-house data. Additional experimental data for further validation will be generated and used, including dual experimental assay of scRNA-seq and scATAC-seq. Final results of the community challenge will be disseminated in multiple ways, including scientific manuscript. | $200,191 |
Over the last fiscal year, we have identified 7 grants that Sage Bionetworks has recieved totaling $2,692,733.
Awarding Organization | Amount |
---|---|
Cancer Research Institute Inc New York, NY PURPOSE: RESEARCH | $1,867,282 |
Childrens Tumor Foundation New York, NY PURPOSE: RESEARCH - CONTRACT AWARDS | $480,105 |
Leona M & Harry B Helmsley Charitable Trust New York, NY PURPOSE: EXTENSION OF VEOIBD DATA COORDINATION | $75,165 |
Leona M & Harry B Helmsley Charitable Trust New York, NY PURPOSE: EXTENSION OF VEOIBD DATA COORDINATION | $73,424 |
Leona M & Harry B Helmsley Charitable Trust New York, NY PURPOSE: EXTENSION OF VEOIBD DATA COORDINATION | $71,204 |
Mayo Clinic Group Return Rochester, MN PURPOSE: SUPPORT CHARITABLE PROGRAMS | $69,227 |
Organization Name | Assets | Revenue |
---|---|---|
Institute For Systems Biology Renton, WA | $80,193,323 | $39,847,320 |
Sage Bionetworks Seattle, WA | $7,319,840 | $26,396,727 |
Portland Va Research Foundation Inc Portland, OR | $12,517,323 | $7,209,614 |
Foundation For Anthropological Research And Environmental Studies Rupert, ID | $156,573 | $645,564 |
Oregon Institute Of Science And Medicine Cave Junction, OR | $1,733,907 | $228,213 |
American Genetic Association South Beach, OR | $4,424,166 | $488,686 |
Friends Of Cooper Island Seattle, WA | $109,283 | $0 |
Cascades Carnivore Project Hood River, OR | $65,810 | $0 |
Orca Behavior Institute Friday Harbor, WA | $123,210 | $0 |
North American Mycological Assn Olympia, WA | $428,904 | $0 |
Biodiversity Research Collective Ashland, OR | $3,652 | $0 |
Enuval Vancouver, WA | $0 | $7,097 |